| Language of instruction: English |
| | | Exam contract: not possible |
There is no data for this choice.
Change the language, year or choose another item in the dropdown list if it is available.
There is no data for this choice.
Change the language, year or choose another item in the dropdown list if it is available.
| Degree programme | | Study hours | Credits | P4 SBU | P4 SP | 2nd Chance Exam1 | Tolerance2 | Final grade3 | |
 | 1st year Master of Biomedical Sciences - Environmental Health Sciences | Compulsory | 81 | 3,0 | 81 | 3,0 | Yes | Yes | Numerical |  |
|
| | | Learning outcomes |
- EC
| 1. A graduate of the Master of Biomedical Sciences has a thorough knowledge of the molecular and cellular processes of the healthy and diseased organism and has insight in different methods for prevention, diagnosis and therapy of diseases. | - EC
| 2. A graduate of the Master of Biomedical Sciences can independently and critically perform a literature search. | - EC
| 3. A graduate of the Master of Biomedical Sciences can draw up a new research hypothesis based on his or her own findings or based on the findings of others, and work out a research proposal for this. | - EC
| 4. A graduate of the Master of Biomedical Sciences has knowledge of state-of-the-art techniques within biomedical research and is able to apply these techniques, taking into account the applicable quality standards. | - EC
| 7. A graduate of the Master of Biomedical Sciences takes a critical attitude towards one's own research and that of others. | - EC
| 12. A graduate of the Master of Biomedical Sciences has an attitude for lifelong learning and for constantly adjusting one's own professional thinking and acting. |
|
| | EC = learning outcomes DC = partial outcomes BC = evaluation criteria |
|
|
|
Course content:
- Introduction to “Drug delivery, Pharmacology, and Toxicology”
- PART 1: From basic to controlled drug delivery
- Pharmacokinetics of drugs
- Drug delivery systems: from basic to controlled
- Toxicity tests
- PART 2: Advanced drug delivery
- Targeting strategies and its clinical applications
- Barriers to overcome
- Toxicity of ‘new emerging compounds'
- PART 3: Preclinical Validation
- Preclinical validation using case studies
Learning goals:
- The student has insight in the pharmacokinetics of drugs
- The student can explain different drug delivery systems typically used for drug delivery, including controlled release
- The student can explain active and passive targeting drug delivery and has insight in its potential applications
- The student has insight in (particle) toxicity of drug delivery systems and how to take this into account in validation studies
- The student has insight in the trajectory of validation studies and can relate the interplay between research and clinical phases (MHD/KBW/Elective course)
|
|
|
|
|
|
|
|
|
Assignment ✔
|
|
|
|
Lecture ✔
|
|
|
|
|
|
|
|
Discussion/debate ✔
|
|
|
|
Group work ✔
|
|
|
|
Journal club ✔
|
|
|
|
Presentation ✔
|
|
|
|
Report ✔
|
|
|
|
Quarter 4 (3,00sp)
| Evaluation method | |
|
| Written evaluation during teaching period | 20 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
| Multiple-choice questions | ✔ |
|
|
|
|
|
|
| Oral evaluation during teaching period | 5 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Other | Moderator skills during journal club |
|
|
|
|
|
|
| Evaluation conditions (participation and/or pass) | ✔ |
|
| Conditions | Participation during assignments is compulsory |
|
|
|
| Consequences | You cannot be evaluated on your knowledge of the journal club paper and moderator skills during the assignment |
|
|
|
Second examination period
| Evaluation second examination opportunity different from first examination opprt | |
|
|
| Compulsory textbooks (bookshop) |
| |
[],[],[],[],[],[All lecture materials will be available on blackboard.] |
|
|
|
|
|
| 1st year Master of Biomedical Sciences - Molecular Mechanisms in Health and Disease | Compulsory | 108 | 4,0 | 108 | 4,0 | Yes | Yes | Numerical | |
|
| | | Learning outcomes |
- EC
| 1. A graduate of the Master of Biomedical Sciences has a thorough knowledge of the molecular and cellular processes of the healthy and diseased organism and has insight in different methods for prevention, diagnosis and therapy of diseases. | - EC
| 2. A graduate of the Master of Biomedical Sciences can independently and critically perform a literature search. | - EC
| 4. A graduate of the Master of Biomedical Sciences has knowledge of state-of-the-art techniques within biomedical research and is able to apply these techniques, taking into account the applicable quality standards. | - EC
| 7. A graduate of the Master of Biomedical Sciences takes a critical attitude towards one's own research and that of others. | - EC
| 10. A graduate of the Master of Biomedical Sciences knows the potential for valorization of biomedical research and can translate own research into translational research. | - EC
| 12. A graduate of the Master of Biomedical Sciences has an attitude for lifelong learning and for constantly adjusting one's own professional thinking and acting. |
|
| | EC = learning outcomes DC = partial outcomes BC = evaluation criteria |
|
|
|
Course content:
- Introduction to “Drug delivery, Pharmacology, and Toxicology”
- PART 1: From basic to controlled drug delivery
- Pharmacokinetics of drugs
- Drug delivery systems: from basic to controlled
- Toxicity tests
- PART 2: Advanced drug delivery
- Targeting strategies and its clinical applications
- Barriers to overcome
- Toxicity of ‘new emerging compounds'
- PART 3: Preclinical Validation
- Preclinical validation using case studies
Learning goals:
- The student has insight in the pharmacokinetics of drugs
- The student can explain different drug delivery systems typically used for drug delivery, including controlled release
- The student can explain active and passive targeting drug delivery and has insight in its potential applications
- The student has insight in (particle) toxicity of drug delivery systems and how to take this into account in validation studies
- The student has insight in the trajectory of validation studies and can relate the interplay between research and clinical phases (MHD/KBW/Elective course)
|
|
|
|
|
|
|
|
|
Assignment ✔
|
|
|
|
Lecture ✔
|
|
|
|
|
|
|
|
Discussion/debate ✔
|
|
|
|
Group work ✔
|
|
|
|
Journal club ✔
|
|
|
|
Presentation ✔
|
|
|
|
Report ✔
|
|
|
|
Quarter 4 (4,00sp)
| Evaluation method | |
|
| Written evaluation during teaching period | 35 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Multiple-choice questions | ✔ |
|
|
|
|
|
|
| Oral evaluation during teaching period | 5 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Other | Discussion/Interaction and moderator skills during presentations |
|
|
|
|
|
|
| Evaluation conditions (participation and/or pass) | ✔ |
|
| Conditions | Participation in assignments is compulsory |
|
|
|
| Consequences | You cannot be evaluated on your discussion/interaction skills or presentation/moderator skills during the assignment |
|
|
|
Second examination period
| Evaluation second examination opportunity different from first examination opprt | |
|
|
| Compulsory textbooks (bookshop) |
| |
[],[],[],[],[],[All lecture materials will be available on blackboard.] |
|
|
|
|
|
| first year Master of Biomedical Sciences - Clinical Biomedical Sciences | Compulsory | 108 | 4,0 | 108 | 4,0 | Yes | Yes | Numerical | |
|
| | | Learning outcomes |
- EC
| 1. A graduate of the Master of Biomedical Sciences has a thorough knowledge of the molecular and cellular processes of the healthy and diseased organism and has insight in different methods for prevention, diagnosis and therapy of diseases. | - EC
| 2. A graduate of the Master of Biomedical Sciences can independently and critically perform a literature search | - EC
| 4. A graduate of the Master of Biomedical Sciences has knowledge of state-of-the-art techniques within biomedical research and is able to apply these techniques, taking into account the applicable quality standards. | - EC
| 7. A graduate of the Master of Biomedical Sciences takes a critical attitude towards one's own research and that of others. | - EC
| 10. A graduate of the Master of Biomedical Sciences knows the potential for valorization of biomedical research and can translate own research into translational research. | - EC
| 12. A graduate of the Master of Biomedical Sciences has an attitude for lifelong learning and for constantly adjusting one's own professional thinking and acting. |
|
| | EC = learning outcomes DC = partial outcomes BC = evaluation criteria |
|
|
|
Course content:
- Introduction to “Drug delivery, Pharmacology, and Toxicology”
- PART 1: From basic to controlled drug delivery
- Pharmacokinetics of drugs
- Drug delivery systems: from basic to controlled
- Toxicity tests
- PART 2: Advanced drug delivery
- Targeting strategies and its clinical applications
- Barriers to overcome
- Toxicity of ‘new emerging compounds'
- PART 3: Preclinical Validation
- Preclinical validation using case studies
Learning goals:
- The student has insight in the pharmacokinetics of drugs
- The student can explain different drug delivery systems typically used for drug delivery, including controlled release
- The student can explain active and passive targeting drug delivery and has insight in its potential applications
- The student has insight in (particle) toxicity of drug delivery systems and how to take this into account in validation studies
- The student has insight in the trajectory of validation studies and can relate the interplay between research and clinical phases (MHD/KBW/Elective course)
|
|
|
|
|
|
|
|
|
Assignment ✔
|
|
|
|
Lecture ✔
|
|
|
|
|
|
|
|
Discussion/debate ✔
|
|
|
|
Group work ✔
|
|
|
|
Journal club ✔
|
|
|
|
Presentation ✔
|
|
|
|
Report ✔
|
|
|
|
Quarter 4 (4,00sp)
| Evaluation method | |
|
| Written evaluation during teaching period | 35 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Multiple-choice questions | ✔ |
|
|
|
|
|
|
| Oral evaluation during teaching period | 5 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Other | Discussion/Interaction and moderator skills during presentations |
|
|
|
|
|
|
| Evaluation conditions (participation and/or pass) | ✔ |
|
| Conditions | Participation in assignments is compulsory |
|
|
|
| Consequences | You cannot be evaluated on your discussion/interaction skills or presentation/moderator skills during the assignment |
|
|
|
Second examination period
| Evaluation second examination opportunity different from first examination opprt | |
|
|
| Compulsory textbooks (bookshop) |
| |
[],[],[],[],[],[All lecture materials will be available on blackboard.] |
|
|
|
|
|
| 1st year Master of Biomedical Sciences - Bioelectronics and Nanotechnology | Optional | 108 | 4,0 | 108 | 4,0 | Yes | Yes | Numerical | |
|
| | | Learning outcomes |
- EC
| 1. A graduate of the Master of Biomedical Sciences has a thorough knowledge of the molecular and cellular processes of the healthy and diseased organism and has insight in different methods for prevention, diagnosis and therapy of diseases. | - EC
| 2. A graduate of the Master of Biomedical Sciences can independently and critically perform a literature search. | - EC
| 3. A graduate of the Master of Biomedical Sciences can draw up a new research hypothesis based on his or her own findings or based on the findings of others, and work out a research proposal for this. | - EC
| 4. A graduate of the Master of Biomedical Sciences has knowledge of state-of-the-art techniques within biomedical research and is able to apply these techniques, taking into account the applicable quality standards. | - EC
| 7. A graduate of the Master of Biomedical Sciences takes a critical attitude towards one's own research and that of others. | - EC
| 10. A graduate of the Master of Biomedical Sciences knows the potential for valorization of biomedical research and can translate own research into translational research. | - EC
| 12. A graduate of the Master of Biomedical Sciences has an attitude for lifelong learning and for constantly adjusting one's own professional thinking and acting. |
|
| | EC = learning outcomes DC = partial outcomes BC = evaluation criteria |
|
|
|
Course content:
- Introduction to “Drug delivery, Pharmacology, and Toxicology”
- PART 1: From basic to controlled drug delivery
- Pharmacokinetics of drugs
- Drug delivery systems: from basic to controlled
- Toxicity tests
- PART 2: Advanced drug delivery
- Targeting strategies and its clinical applications
- Barriers to overcome
- Toxicity of ‘new emerging compounds'
- PART 3: Preclinical Validation
- Preclinical validation using case studies
Learning goals:
- The student has insight in the pharmacokinetics of drugs
- The student can explain different drug delivery systems typically used for drug delivery, including controlled release
- The student can explain active and passive targeting drug delivery and has insight in its potential applications
- The student has insight in (particle) toxicity of drug delivery systems and how to take this into account in validation studies
- The student has insight in the trajectory of validation studies and can relate the interplay between research and clinical phases (MHD/KBW/Elective course)
|
|
|
|
|
|
|
|
|
Assignment ✔
|
|
|
|
Lecture ✔
|
|
|
|
|
|
|
|
Discussion/debate ✔
|
|
|
|
Group work ✔
|
|
|
|
Journal club ✔
|
|
|
|
Presentation ✔
|
|
|
|
Report ✔
|
|
|
|
Quarter 4 (4,00sp)
| Evaluation method | |
|
| Written evaluation during teaching period | 35 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Multiple-choice questions | ✔ |
|
|
|
|
|
|
| Oral evaluation during teaching period | 5 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Other | Discussion/Interaction and moderator skills during presentations |
|
|
|
|
|
|
| Evaluation conditions (participation and/or pass) | ✔ |
|
| Conditions | Participation in assignments is compulsory |
|
|
|
| Consequences | You cannot be evaluated on your discussion/interaction skills or presentation/moderator skills during the assignment |
|
|
|
Second examination period
| Evaluation second examination opportunity different from first examination opprt | |
|
|
| Compulsory textbooks (bookshop) |
| |
[],[],[],[],[],[All lecture materials will be available on blackboard.] |
|
|
|
|
|
| Master of Teaching in Health Sciences keuzetraject BMW/GEN met vakdidactiek biologie | Optional | 108 | 4,0 | 108 | 4,0 | Yes | Yes | Numerical | |
| Master of Teaching in Health Sciences keuzetraject BMW/GEN met vakdidactiek chemie | Optional | 108 | 4,0 | 108 | 4,0 | Yes | Yes | Numerical | |
|
| | | Learning outcomes |
- EC
| The newly graduated student has insight into the construction and functioning of the diseased and healthy human body (at the molecular, cellular, organ and organism level). |
|
| | EC = learning outcomes DC = partial outcomes BC = evaluation criteria |
|
|
|
Course content:
- Introduction to “Drug delivery, Pharmacology, and Toxicology”
- PART 1: From basic to controlled drug delivery
- Pharmacokinetics of drugs
- Drug delivery systems: from basic to controlled
- Toxicity tests
- PART 2: Advanced drug delivery
- Targeting strategies and its clinical applications
- Barriers to overcome
- Toxicity of ‘new emerging compounds'
- PART 3: Preclinical Validation
- Preclinical validation using case studies
Learning goals:
- The student has insight in the pharmacokinetics of drugs
- The student can explain different drug delivery systems typically used for drug delivery, including controlled release
- The student can explain active and passive targeting drug delivery and has insight in its potential applications
- The student has insight in (particle) toxicity of drug delivery systems and how to take this into account in validation studies
- The student has insight in the trajectory of validation studies and can relate the interplay between research and clinical phases (MHD/KBW/Elective course)
|
|
|
|
|
|
|
|
|
Assignment ✔
|
|
|
|
Lecture ✔
|
|
|
|
|
|
|
|
Discussion/debate ✔
|
|
|
|
Group work ✔
|
|
|
|
Journal club ✔
|
|
|
|
Presentation ✔
|
|
|
|
Report ✔
|
|
|
|
Quarter 4 (4,00sp)
| Evaluation method | |
|
| Written evaluation during teaching period | 35 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Multiple-choice questions | ✔ |
|
|
|
|
|
|
| Oral evaluation during teaching period | 5 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Other | Discussion/Interaction and moderator skills during presentations |
|
|
|
|
|
|
| Evaluation conditions (participation and/or pass) | ✔ |
|
| Conditions | Participation in assignments is compulsory |
|
|
|
| Consequences | You cannot be evaluated on your discussion/interaction skills or presentation/moderator skills during the assignment |
|
|
|
Second examination period
| Evaluation second examination opportunity different from first examination opprt | |
|
|
| Compulsory textbooks (bookshop) |
| |
[],[],[],[],[],[All lecture materials will be available on blackboard.] |
|
|
|
|
|
1 Education, Examination and Legal Position Regulations art.12.2, section 2. |
| 2 Education, Examination and Legal Position Regulations art.16.9, section 2. |
3 Education, Examination and Legal Position Regulations art.15.1, section 3.
|
| Legend |
| SBU : course load | SP : ECTS | N : Dutch | E : English |
|